bpc 157 and pregnancy BPC-157 – Mark Hyman, MD BPC-157 – America First Labs

The company makes its Certificate of Analysis available on the product page

Recurrent infections or inflammatory markers increase

+ - According to published rat pharmacokinetic research quantified via LC-MS/MS detection, oral-administered 5-amino-1MQ (shortened as 5-AMQ) has a mean terminal elimination half-life of roughly 6.90 1.20 hours, while its intravenous counterpart displays a shorter half-life averaging 3.80 1.10 hours

Reduction of Inflammation and Oxidative Stress : BPC-157 and TB-500 work synergistically to reduce inflammatory cytokines such as TNF- and IL-6 and to mitigate oxidative stress markers in damaged tissues

No, it is not FDA-approved, and much of the evidence is preclinical

It contains 0.9% (9 mg/mL) benzyl alcohol, which functions as a bacteriostatic preservative by inhibiting microbial growth in the vial